Search

everythinglearnresearchcommunity

for

Search:↓

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Safflower extract helps protect hair follicle cells from damage caused by chemotherapy.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Melatonin is important for skin health and protection, and can be made by the skin or applied to it.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Hair loss requires customized treatments based on its various causes and types.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.